Company Silk Road Medical, Inc

Equities

SILK

US82710M1009

Medical Equipment, Supplies & Distribution

Market Closed - Nasdaq 01:30:00 17/05/2024 am IST 5-day change 1st Jan Change
22.45 USD +3.65% Intraday chart for Silk Road Medical, Inc +16.74% +82.97%

Business Summary

Silk Road Medical, Inc. is a medical device company that is focused on reducing the risk of stroke and its impact. The Company has developed an approach for the treatment of carotid artery disease called TransCarotid Artery Revascularization (TCAR). TCAR is a clinically proven procedure combining surgical principles of neuroprotection with minimally invasive endovascular techniques to treat blockages in the carotid artery at risk of causing a stroke. Its product portfolio consists of five single-use components: ENROUTE Transcarotid Neuroprotection System, ENROUTE Transcarotid Stent System, ENHANCE Transcarotid Peripheral Access Kit, ENROUTE 0.014'' Guidewire and ENROUTE Enflate Transcarotid RX Balloon Dilation Catheter. It manufactures ENROUTE NPS and ENROUTE NPS PLUS, or its ENROUTE NPS products, at its facilities in Sunnyvale, California and Plymouth, Minnesota. These facilities provide an aggregate of over 35,000 square feet of space for its production and distribution operations.

Number of employees: 474

Sales per Business

USD in Million2022Weight2023Weight Delta
Transcarotid Artery Revascularization
100.0 %
139 100.0 % 177 100.0 % +27.77%

Sales per region

USD in Million2022Weight2023Weight Delta
United States
100.0 %
139 100.0 % 177 100.0 % +27.77%

Managers

Managers TitleAgeSince
Chief Executive Officer 55 02/11
Director of Finance/CFO 46 01/09/01
Chief Tech/Sci/R&D Officer - 21/20/21
Compliance Officer - 01/17/01
Chief Tech/Sci/R&D Officer - 13/14/13
General Counsel - 01/20/01
Corporate Officer/Principal - -
Corporate Officer/Principal - 01/15/01
Human Resources Officer - 01/17/01
Corporate Officer/Principal 55 28/15/28

Members of the board

Members of the board TitleAgeSince
Director/Board Member 56 26/18/26
Director/Board Member 51 03/20/03
Chairman 70 01/07/01
Director/Board Member 64 01/13/01
Director/Board Member 63 01/20/01
Founder 63 01/07/01
Director/Board Member 49 22/21/22
Chief Executive Officer 55 02/11

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 39,443,868 37,763,394 ( 95.74 %) 0 95.74 %

Shareholders

NameEquities%Valuation
Wasatch Advisors, Inc.
11.61 %
4,549,742 11.61 % 80 M $
Capital Research & Management Co. (World Investors)
7.943 %
3,111,730 7.943 % 55 M $
Vanguard Fiduciary Trust Co.
7.460 %
2,922,495 7.460 % 52 M $
BlackRock Advisors LLC
7.342 %
2,876,224 7.342 % 51 M $
Morgan Stanley Investment Management, Inc.
4.678 %
1,832,750 4.678 % 32 M $
D.E. Shaw & Co., Inc.
4.083 %
1,599,491 4.083 % 28 M $
Bellevue Asset Management AG
3.876 %
1,518,230 3.876 % 27 M $
BAMCO, Inc.
3.829 %
1,500,170 3.829 % 26 M $
Sofinnova Investments, Inc.
3.035 %
1,189,024 3.035 % 21 M $
Tri Locum Partners LP
2.766 %
1,083,605 2.766 % 19 M $

Company contact information

Silk Road Medical, Inc.

1213 Innsbruck Drive

94089, Sunnyvale

+408 720 9002

http://www.silkroadmed.com
address Silk Road Medical, Inc(SILK)
  1. Stock Market
  2. Equities
  3. SILK Stock
  4. Company Silk Road Medical, Inc
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW